• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tempest Therapeutics, Inc. - Common Stock (NQ:TPST)

    0.8166 -0.0124 (-1.50%)
    Streaming Delayed Price Updated: 2:13 PM EDT, Sep 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 154,317
    Open 0.8250
    Bid (Size) 0.8166 (200)
    Ask (Size) 0.8279 (100)
    Prev. Close 0.8290
    Today's Range 0.8000 - 0.8280
    52wk Range 0.7432 - 12.23
    Shares Outstanding 11,586,406
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
    Accomplished finance and enterprise executive with over 20 years of global leadership in multinational and Fortune 500 companies 
    From Tempest Therapeutics
    Via GlobeNewswire
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill

    Performance

    YTD
    -72.3%
    -72.3%
    1 Month
    -23.0%
    -23.0%
    3 Month
    -25.8%
    -25.8%
    6 Month
    -46.3%
    -46.3%
    1 Year
    -92.0%
    -92.0%

    More News

    Read More
    Unusual volume stocks in Friday's session ↗
    Via Chartmill
    Top movers in Thursday's session ↗
    Via Chartmill
    Which stocks have an unusual volume on Thursday? ↗
    Via Chartmill
    Here are the top movers in Thursday's session. ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    What's going on in today's session ↗
    Via Chartmill
    These stocks have an unusual volume in today's session ↗
    Via Chartmill
    Keep an eye on the top gainers and losers in Wednesday's session. ↗
    Via Chartmill
    Gapping stocks in Wednesday's session ↗
    Via Chartmill
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform
    From Tempest Therapeutics
    Via GlobeNewswire
    News headline image
    Tempest Therapeutics Announces Up to $7.5 Million Private Placement
    From Tempest Therapeutics
    Via GlobeNewswire
    News headline image
    Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
    From Tempest Therapeutics
    Via GlobeNewswire
    News headline image
    Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update
    From Tempest Therapeutics
    Via GlobeNewswire
    News headline image
    Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
    From Tempest Therapeutics
    Via GlobeNewswire
    News headline image
    Tempest Unveils Next-Generation In Vivo CAR-T Pipeline, with First Clinical Study Planned for the Fourth Quarter of 2026
    From Tempest Therapeutics
    Via GlobeNewswire
    Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
    Via Chartmill
    News headline image
    Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
    From Tempest Therapeutics
    Via GlobeNewswire
    News headline image
    Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
    From Tempest Therapeutics
    Via GlobeNewswire
    News headline image
    Tempest Reports First Quarter 2026 Financial Results and Provides Business Update
    From Tempest Therapeutics
    Via GlobeNewswire

    Frequently Asked Questions

    Is Tempest Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Tempest Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Tempest Therapeutics, Inc. - Common Stock trade on?
    Tempest Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tempest Therapeutics, Inc. - Common Stock?
    The ticker symbol for Tempest Therapeutics, Inc. - Common Stock is TPST on the Nasdaq Stock Market
    What is the current price of Tempest Therapeutics, Inc. - Common Stock?
    The current price of Tempest Therapeutics, Inc. - Common Stock is 0.8166
    When was Tempest Therapeutics, Inc. - Common Stock last traded?
    The last trade of Tempest Therapeutics, Inc. - Common Stock was at 09/28/26 02:13 PM ET
    What is the market capitalization of Tempest Therapeutics, Inc. - Common Stock?
    The market capitalization of Tempest Therapeutics, Inc. - Common Stock is 9.46M
    How many shares of Tempest Therapeutics, Inc. - Common Stock are outstanding?
    Tempest Therapeutics, Inc. - Common Stock has 9M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.